RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

DnB Asset Management AS's Holding History (CIK: 0001456670)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 313,707 Value ($000) $1,531 Avg Close $5.25 Range $4.45 - $7.15

Q1 2025

Shares 18,917 Value ($000) $100 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 85,365 Value ($000) $577 Avg Close $6.72 Range $5.60 - $9.55

Q2 2024

Shares 33,119 Value ($000) $248 Avg Close $8.72 Range $6.75 - $10.66

Q3 2022

Shares 26,086 Value ($000) $277,294 Avg Close $10.13 Range $7.48 - $14.18

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	313,707	$1,531	$5.25	$4.45 - $7.15
Q1 2025	18,917	$100	$7.29	$5.19 - $12.36
Q4 2024	85,365	$577	$6.72	$5.60 - $9.55
Q2 2024	33,119	$248	$8.72	$6.75 - $10.66
Q3 2022	26,086	$277,294	$10.13	$7.48 - $14.18